MapMySmoke: Smoking Cessation App With Geospatial Capture

May 19, 2017 updated by: Robert Schick, University of St Andrews

MapMySmoke: Feasibility of a New Quit Cigarette Smoking Mobile Phone Application Using Integrated Geo-positioning Technology, and Motivational Messaging Within Primary Care Setting

Place-based cues can be an important trigger of smoking behavior, therefore the investigators wish to learn more about the influence of the built environment on individual smoking behavior. This is to facilitate dynamic support during the post-quit phase. MapMySmoke is a mobile phone application that enables the capture of spatial data during smoking and craving events. These data will be used to create individualized support plans via the app.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Investigators know that place-based cues play an important role in the triggering of smoking events, and even in relapse events. It follows that providing individual smokers with spatially explicit and temporally dynamic intervention messages may support smoking cessation attempts.

The investigators have built a mobile phone application-MayMySmoke-that allows individuals to capture each smoking event at the times and places they occur, and tag the events with qualitative metadata. The app also allows individuals to document and describe craving events. The goal of the app is first to understand an individual's smoking profile, and second to support them with dynamic text messages.

The investigators are deploying the app in a clinical setting-the United Kingdom's National Health Service, within the Fife region of Scotland. Using two feasibility studies of increasing size, the investigators are attempting first to get initial feedback on the app, and then to improve the app and deploy it across a broader community of smokers.

Though the app is targeted to smoking behavior, it is possible to extend it to include other negative health behaviors that may have a spatial component.

Study Type

Interventional

Enrollment (Anticipated)

110

Phase

  • Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • National Health Service (Fife) Patients
  • Self-reported tobacco smoker
  • Stated intention to quit smoking
  • English speaker

Exclusion Criteria:

  • Mental illness
  • learning difficulty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MapMySmoke
All patients in the study will use the MapMySmoke app to document their smoking and craving behavior
Each patient in the study arm will download and install the MapMySmoke app to record all of their smoking and craving events. The app will generate a quantitative summary of their smoking behavior during a pre-quit phase, and will provide dynamic text support messages during the post-quit phase. The app will also capture spatial details of any relapse events during the post-quit phase.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Continued use of the MapMySmoke App as Assessed by Monitoring Individual Anonymized Data Feeds on the Server
Time Frame: 1 year
The investigators will determine, via the data feed to the server, if patients continue to use the app during the pre- and post-quit phase
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Patients Using the App Who Are Abstinent from Smoking As Assessed by Follow-up Survey
Time Frame: 4 weeks
The investigators will determine via survey if patients have maintained their quit attempt
4 weeks
Number of Patients Using the App Who Are Abstinent from Smoking As Assessed by Follow-up Survey
Time Frame: 3 months
The investigators will determine via survey if patients have maintained their quit attempt
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert S Schick, PhD, University of St Andrews

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2016

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

December 1, 2017

Study Registration Dates

First Submitted

October 12, 2016

First Submitted That Met QC Criteria

October 12, 2016

First Posted (Estimate)

October 13, 2016

Study Record Updates

Last Update Posted (Actual)

May 22, 2017

Last Update Submitted That Met QC Criteria

May 19, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • XAP062

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

3
Subscribe